Nuttawadee Intachai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nuttawadee Intachai has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Anusorn Lungkaphin
Renal Transporter and Molecular Signaling Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
2 shared publications - Aye Thidar Moe Moe
Center of Radiation Research and Medical Imaging, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
2 shared publications - Christopher Lai
School of Medical and Health Sciences, Tung Wah College, Hong Kong, China
2 shared publications - Hong Joo Kim
Department of Physics, Kyungpook National University, Daegu 41566, Republic of Korea
2 shared publications - Jakrapong Kaewkhao
Center of Excellence in Glass Technology and Materials Science (CEGM), Faculty of Science and Technology, Nakhon Pathom Rajabhat University, Nakhon Pathom 73000, Thailand
2 shared publications - Khin Thandar Htun
Center of Radiation Research and Medical Imaging, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
2 shared publications
Latest Publications
- Open Access
Quercetin Reduces Lipid Accumulation During Adipogenic Differentiation in Association with Stage-Dependent Mitochondrial-Redox and Metabolic Alterations Revealed by Time-Resolved 1H NMR Metabolomics
(1) Background: Adipocyte differentiation involves coordinated changes in mitochondrial activity, redox balance, and cellular metabolism. Here, we examined how quercetin affects lipid accumulation and associated mitochondrial-redox and metabolic features during 3T3-L1 adipogenic differentiation by combining functional assays with time-resolved 1H NMR metabolomics. (2) Materials and methods: 3T3-L1 cells were differentiated for six days in the absence or presence of 20 μM quercetin. Lipid accumulation, mitochondrial membrane potential, intracellular reactive oxygen species (ROS), and intracellular metabolite profiles were assessed at defined stages of differentiation. (3) Results: Quercetin reduced lipid accumulation, mitochondrial membrane potential, and ROS accumulation, particularly at the mid-to-late stages of adipogenic differentiation. 1H NMR analysis showed lower lipid-associated resonances and changes in metabolites related to energy metabolism, choline metabolism, and amino acid metabolism in quercetin-treated cells. Orthogonal partial least squares-discriminant analysis (OPLS-DA) showed separation of the metabolic profiles of untreated and quercetin-treated cells at each measured stage. The variables contributing to this separation included lipid-associated resonances, lactate, 3-hydroxybutyrate, choline-related metabolites, and selected amino acids. (4) Conclusions: The results indicate that quercetin reduces lipid accumulation during adipogenic differentiation in association with changes in mitochondrial-redox status and intracellular metabolic profiles. Overall, the findings support stage-dependent alterations of metabolic profiles in quercetin-treated 3T3-L1 cells during adipogenic differentiation.
Open AccessQuercetin Reduces Lipid Accumulation During Adipogenic Differentiation in Association with Stage-Dependent Mitochondrial-Redox and Metabolic Alterations Revealed by Time-Resolved 1H NMR Metabolomics
(1) Background: Adipocyte differentiation involves coordinated changes in mitochondrial activity, redox balance, and cellular metabolism. Here, we examined how quercetin affects lipid accumulation and associated mitochondrial-redox and metabolic features during 3T3-L1 adipogenic differentiation by combining functional assays with time-resolved 1H NMR metabolomics. (2) Materials and methods: 3T3-L1 cells were differentiated for six days in the absence or presence of 20 μM quercetin. Lipid accumulation, mitochondrial membrane potential, intracellular reactive oxygen species (ROS), and intracellular metabolite profiles were assessed at defined stages of differentiation. (3) Results: Quercetin reduced lipid accumulation, mitochondrial membrane potential, and ROS accumulation, particularly at the mid-to-late stages of adipogenic differentiation. 1H NMR analysis showed lower lipid-associated resonances and changes in metabolites related to energy metabolism, choline metabolism, and amino acid metabolism in quercetin-treated cells. Orthogonal partial least squares-discriminant analysis (OPLS-DA) showed separation of the metabolic profiles of untreated and quercetin-treated cells at each measured stage. The variables contributing to this separation included lipid-associated resonances, lactate, 3-hydroxybutyrate, choline-related metabolites, and selected amino acids. (4) Conclusions: The results indicate that quercetin reduces lipid accumulation during adipogenic differentiation in association with changes in mitochondrial-redox status and intracellular metabolic profiles. Overall, the findings support stage-dependent alterations of metabolic profiles in quercetin-treated 3T3-L1 cells during adipogenic differentiation.
- Open Access
- 4 July 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (7) , 830
Pentagalloyl Glucose and Cisplatin Combination Treatment Exhibits a Synergistic Anticancer Effect in 2D and 3D Models of Head and Neck Carcinoma
Although cisplatin is a first-line chemotherapy drug for head and neck squamous cell carcinoma (HNSCC), its therapeutic efficacy is limited owing to serious side effects and acquired drug resistance. This study determined whether combining pentagalloyl glucose (PGG) and cisplatin enhanced their anti-tumor activities on HNSCC cell lines. We investigated the anticancer effect of PGG combined with cisplatin in 2D and 3D multicellular spheroid cell culture. The results revealed that PGG combined with cisplatin inhibited cell viability and produced synergistic effects. PGG potentiates the anticancer effect of cisplatin by promoting apoptosis and inhibiting cell migration. The western blot and molecular docking analysis revealed that the synergistic effect of the combination treatment may be related to the PGG-mediated reduced expression of phosphorylated STAT3 and phosphorylated Akt. Furthermore, we found that the combined treatment of PGG and cisplatin’s effect on 3D multicellular spheroid size was more potent than the monotherapies. Our findings indicated that the combination therapy of PGG and cisplatin synergistically inhibited HNSCC cancer cell viability and induced apoptosis in 2D and 3D models. The present results suggested that PGG may be a promising adjunct drug used with cisplatin for a practical therapeutic approach to head and neck cancer.
- 4 July 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (7) , 830
Open AccessPentagalloyl Glucose and Cisplatin Combination Treatment Exhibits a Synergistic Anticancer Effect in 2D and 3D Models of Head and Neck Carcinoma
Although cisplatin is a first-line chemotherapy drug for head and neck squamous cell carcinoma (HNSCC), its therapeutic efficacy is limited owing to serious side effects and acquired drug resistance. This study determined whether combining pentagalloyl glucose (PGG) and cisplatin enhanced their anti-tumor activities on HNSCC cell lines. We investigated the anticancer effect of PGG combined with cisplatin in 2D and 3D multicellular spheroid cell culture. The results revealed that PGG combined with cisplatin inhibited cell viability and produced synergistic effects. PGG potentiates the anticancer effect of cisplatin by promoting apoptosis and inhibiting cell migration. The western blot and molecular docking analysis revealed that the synergistic effect of the combination treatment may be related to the PGG-mediated reduced expression of phosphorylated STAT3 and phosphorylated Akt. Furthermore, we found that the combined treatment of PGG and cisplatin’s effect on 3D multicellular spheroid size was more potent than the monotherapies. Our findings indicated that the combination therapy of PGG and cisplatin synergistically inhibited HNSCC cancer cell viability and induced apoptosis in 2D and 3D models. The present results suggested that PGG may be a promising adjunct drug used with cisplatin for a practical therapeutic approach to head and neck cancer.
- Open Access
- 4 July 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (7) , 1621
Noninvasive NMR/MRS Metabolic Parameters to Evaluate Metabolic Syndrome in Rats
(1) Background: Ectopic fat deposition and its effects, metabolic syndrome, have been significantly correlated to lifestyle and caloric consumption. There is no specific noninvasive evaluation tool being used in order to establish clinical markers for tracing the metabolic pathway implicated in obesity-related abnormalities that occur in the body as a result of a high-fat diet (HFD). The purpose of this work is to investigate in vivo ectopic fat distribution and in vitro metabolite profiles given by HFDs, as well as how they are inter-related, in order to find surrogate metabolic biomarkers in the development of metabolic syndrome utilizing noninvasive approaches. (2) Methods: Male Wistar rats were divided into a standard normal chow diet, ND group, and HFD group. After 16 weeks of different diet administration, blood samples were collected for proton nuclear magnetic resonance (1H NMR) and biochemical analysis. Magnetic resonance imaging/proton magnetic resonance spectroscopy (MRI/1H MRS) was performed on the abdomen, liver, and psoas muscle of the rats. (3) Results: Visceral fat showed the strongest relationship with blood cholesterol. Although liver fat content (LFC) was not associated with any biophysical profiles, it had the highest correlation with metabolites such as (-CH2)n very-low-density lipoprotein/low-density lipoprotein (VLDL/LDL), lactate, and N-acetyl glycoprotein of serum 1H NMR. HFD showed no obvious influence on muscle fat accumulation. Acetoacetate, N-acetyl glycoprotein, lactate, (-CH2)n VLDL/LDL, and valine were the five possible metabolic biomarkers used to differentiate HFD from ND in the present study. (4) Conclusions: Our study has validated the influence of long-term HFD-induced ectopic fat on body metabolism as well as the metabolic profile deterioration both in vivo and in vitro.
- 4 July 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (7) , 1621
Open AccessNoninvasive NMR/MRS Metabolic Parameters to Evaluate Metabolic Syndrome in Rats
(1) Background: Ectopic fat deposition and its effects, metabolic syndrome, have been significantly correlated to lifestyle and caloric consumption. There is no specific noninvasive evaluation tool being used in order to establish clinical markers for tracing the metabolic pathway implicated in obesity-related abnormalities that occur in the body as a result of a high-fat diet (HFD). The purpose of this work is to investigate in vivo ectopic fat distribution and in vitro metabolite profiles given by HFDs, as well as how they are inter-related, in order to find surrogate metabolic biomarkers in the development of metabolic syndrome utilizing noninvasive approaches. (2) Methods: Male Wistar rats were divided into a standard normal chow diet, ND group, and HFD group. After 16 weeks of different diet administration, blood samples were collected for proton nuclear magnetic resonance (1H NMR) and biochemical analysis. Magnetic resonance imaging/proton magnetic resonance spectroscopy (MRI/1H MRS) was performed on the abdomen, liver, and psoas muscle of the rats. (3) Results: Visceral fat showed the strongest relationship with blood cholesterol. Although liver fat content (LFC) was not associated with any biophysical profiles, it had the highest correlation with metabolites such as (-CH2)n very-low-density lipoprotein/low-density lipoprotein (VLDL/LDL), lactate, and N-acetyl glycoprotein of serum 1H NMR. HFD showed no obvious influence on muscle fat accumulation. Acetoacetate, N-acetyl glycoprotein, lactate, (-CH2)n VLDL/LDL, and valine were the five possible metabolic biomarkers used to differentiate HFD from ND in the present study. (4) Conclusions: Our study has validated the influence of long-term HFD-induced ectopic fat on body metabolism as well as the metabolic profile deterioration both in vivo and in vitro.